Edible gums—An extensive review on its diverse applications in various food sectors

Kadirvel, Vijayasri; Narayana, Gururaj P.

doi:10.1002/fbe2.12067

Cited by 1 publication

(1 citation statement)

References 132 publications

(139 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dextran-type polysaccharides are used as stabilising agents for parenteral solutions [ 227 ]. Various types of gums (such as xanthan, acacia, and guar) are employed as emulsifying agents or thickening agents [ 228 ]. Lastly, cyclodextrins are used to enhance the absorption of different classes of active substances [ 229 ].…”

Section: Other Pharmacotherapeutic Interactionsmentioning

confidence: 99%

Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions

Marinescu,

Apetroaei,

Nedea

et al. 2024

Nutrients

View full text Add to dashboard Cite

It is widely acknowledged that the ketogenic diet (KD) has positive physiological effects as well as therapeutic benefits, particularly in the treatment of chronic diseases. Maintaining nutritional ketosis is of utmost importance in the KD, as it provides numerous health advantages such as an enhanced lipid profile, heightened insulin sensitivity, decreased blood glucose levels, and the modulation of diverse neurotransmitters. Nevertheless, the integration of the KD with pharmacotherapeutic regimens necessitates careful consideration. Due to changes in their absorption, distribution, metabolism, or elimination, the KD can impact the pharmacokinetics of various medications, including anti-diabetic, anti-epileptic, and cardiovascular drugs. Furthermore, the KD, which is characterised by the intake of meals rich in fats, has the potential to impact the pharmacokinetics of specific medications with high lipophilicity, hence enhancing their absorption and bioavailability. However, the pharmacodynamic aspects of the KD, in conjunction with various pharmaceutical interventions, can provide either advantageous or detrimental synergistic outcomes. Therefore, it is important to consider the pharmacokinetic and pharmacodynamic interactions that may arise between the KD and various drugs. This assessment is essential not only for ensuring patients’ compliance with treatment but also for optimising the overall therapeutic outcome, particularly by mitigating adverse reactions. This highlights the significance and necessity of tailoring pharmacological and dietetic therapies in order to enhance the effectiveness and safety of this comprehensive approach to managing chronic diseases.

show abstract

Section: Other Pharmacotherapeutic Interactionsmentioning

confidence: 99%